ticlopidine has been researched along with defibrotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mantovani, M; Niada, R; Pescador, R; Porta, R; Prino, G | 1 |
| Ochmański, W | 1 |
1 trial(s) available for ticlopidine and defibrotide
| Article | Year |
|---|---|
[Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy in patients with small cell lung cancer. Part I. Influence of AD on the haemostatic system].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Blood Coagulation; Carcinoma, Small Cell; Cyclophosphamide; Dactinomycin; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polydeoxyribonucleotides; Radiotherapy, Adjuvant; Survival Rate; Ticlopidine; Vincristine | 2008 |
1 other study(ies) available for ticlopidine and defibrotide
| Article | Year |
|---|---|
Thrombolytic activity of defibrotide against old venous thrombi.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Heparin; Male; Polydeoxyribonucleotides; Rabbits; Thrombophlebitis; Ticlopidine; Time Factors; Urokinase-Type Plasminogen Activator | 1989 |